Back to list
October 23, 2014
Category: Masterbatches

Clariant hosting IoPP at its Belen, New Mexico production facility

Muttenz, October 23, 2014 – Clariant, a world leader in specialty chemicals, recently hosted the Drug and Pharmaceutical Committee of the Institute of Packaging Professionals (IoPP) at its production facility in Belen, New Mexico.


The Committee is organized to study overall packaging operations and related problems of the drug and pharmaceutical industry. Its objective is to study the technical advances and problems in the packaging area of the pharmaceutical industry. Membership is composed of individuals from companies in the pharmaceutical industry which are involved in the Research and Development of new chemical/biological entities and the manufacturing and marketing of human prescription drugs.


Clariant Healthcare Packaging provided the Committee with a comprehensive plant tour showcasing its latest technologies, including its newest high capacity production lines for its Sorb-it® desiccant canisters and packets. The group also observed Clariant’s manufacturing lines for its container-closure systems, such as its Oxy-Guard® barrier bottles. Included in the visit program was a full briefing on time-of-protection calculations, shelf-life simulation and headspace management, considering active agents, passive barriers and conditions of use.


“We are extremely happy to have hosted this extremely important and renowned Committee at our flagship North America site,” said Andy Walti, Head of Healthcare Packaging at Clariant. “We are confident that the visit helped the Committee in their pursuit of further technical understanding of controlled atmosphere packaging technologies and their impact on drug and packaging development.”


The Committee last visited the Belen site in 2007.

download article
print article
Clariant Media Contact
Global Media Office
Tel: +41 61 469 6363
Image Gallery
Find management and site pictures as well as Clariant logo in our media gallery Media Gallery
News Subscription
Newsletter
Loading...Loading...
Your Name:
Your Email:
Disclaimer